383 related articles for article (PubMed ID: 16700704)
1. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited.
Ergonul O; Celikbas A; Baykam N; Eren S; Dokuzoguz B
Clin Microbiol Infect; 2006 Jun; 12(6):551-4. PubMed ID: 16700704
[TBL] [Abstract][Full Text] [Related]
2. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality.
Cevik MA; Erbay A; Bodur H; Gülderen E; Baştuğ A; Kubar A; Akinci E
Int J Infect Dis; 2008 Jul; 12(4):374-9. PubMed ID: 18063402
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy.
Ergönül O; Celikbaş A; Dokuzoguz B; Eren S; Baykam N; Esener H
Clin Infect Dis; 2004 Jul; 39(2):284-7. PubMed ID: 15307042
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of clinical and laboratory predictors of fatality in patients with Crimean-Congo haemorrhagic fever in a tertiary care hospital in Turkey.
Hatipoglu CA; Bulut C; Yetkin MA; Ertem GT; Erdinc FS; Kilic EK; Sari T; Kinikli S; Oral B; Demiroz AP
Scand J Infect Dis; 2010 Jul; 42(6-7):516-21. PubMed ID: 20166862
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey.
Elaldi N; Bodur H; Ascioglu S; Celikbas A; Ozkurt Z; Vahaboglu H; Leblebicioglu H; Yilmaz N; Engin A; Sencan M; Aydin K; Dokmetas I; Cevik MA; Dokuzoguz B; Tasyaran MA; Ozturk R; Bakir M; Uzun R
J Infect; 2009 Mar; 58(3):238-44. PubMed ID: 19246100
[TBL] [Abstract][Full Text] [Related]
6. Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy.
Ozkurt Z; Kiki I; Erol S; Erdem F; Yilmaz N; Parlak M; Gundogdu M; Tasyaran MA
J Infect; 2006 Mar; 52(3):207-15. PubMed ID: 15953646
[TBL] [Abstract][Full Text] [Related]
7. An outbreak of Crimean-Congo hemorrhagic fever in western Anatolia, Turkey.
Ertugrul B; Uyar Y; Yavas K; Turan C; Oncu S; Saylak O; Carhan A; Ozturk B; Erol N; Sakarya S
Int J Infect Dis; 2009 Nov; 13(6):e431-6. PubMed ID: 19409826
[TBL] [Abstract][Full Text] [Related]
8. Peripheral blood natural killer cells in Crimean-Congo hemorrhagic fever.
Yilmaz M; Aydin K; Akdogan E; Sucu N; Sonmez M; Omay SB; Koksal I
J Clin Virol; 2008 Aug; 42(4):415-7. PubMed ID: 18434247
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of oral ribavirin in the treatment of crimean-congo hemorrhagic fever in Iran.
Mardani M; Jahromi MK; Naieni KH; Zeinali M
Clin Infect Dis; 2003 Jun; 36(12):1613-8. PubMed ID: 12802764
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the efficacy of ribavirin therapy on survival of Crimean-Congo hemorrhagic fever patients: a case-control study.
Izadi S; Salehi M
Jpn J Infect Dis; 2009 Jan; 62(1):11-5. PubMed ID: 19168952
[TBL] [Abstract][Full Text] [Related]
11. Re-evaluation of 400 Crimean-Congo hemorrhagic fever cases in an endemic area: is ribavirin treatment suitable?
Duygu F; Kaya T; Baysan P
Vector Borne Zoonotic Dis; 2012 Sep; 12(9):812-6. PubMed ID: 22007611
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for fatality in patients with Crimean-Congo haemorrhagic fever.
Tasdelen Fisgin N; Tanyel E; Doganci L; Tulek N
Trop Doct; 2009 Jul; 39(3):158-60. PubMed ID: 19535753
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of factors predictive of the prognosis in Crimean-Congo hemorrhagic fever: new suggestions.
Ozturk B; Tutuncu E; Kuscu F; Gurbuz Y; Sencan I; Tuzun H
Int J Infect Dis; 2012 Feb; 16(2):e89-93. PubMed ID: 22154082
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey.
Koksal I; Yilmaz G; Aksoy F; Aydin H; Yavuz I; Iskender S; Akcay K; Erensoy S; Caylan R; Aydin K
J Clin Virol; 2010 Jan; 47(1):65-8. PubMed ID: 19962342
[TBL] [Abstract][Full Text] [Related]
15. Analysis of lymphocyte subgroups in Crimean-Congo hemorrhagic fever.
Akinci E; Yilmaz M; Bodur H; Ongürü P; Bayazit FN; Erbay A; Ozet G
Int J Infect Dis; 2009 Sep; 13(5):560-3. PubMed ID: 19112036
[TBL] [Abstract][Full Text] [Related]
16. Crimean-Congo haemorrhagic fever cases in Turkey.
Gozalan A; Esen B; Fitzner J; Tapar FS; Ozkan AP; Georges-Courbot MC; Uzun R; Gumuslu F; Akin L; Zeller H
Scand J Infect Dis; 2007; 39(4):332-6. PubMed ID: 17454897
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of PCR and ELISA-IgM results in the laboratory diagnosis of Crimean-Congo haemorrhagic fever cases in 2008 in Turkey].
Uyar Y; Carhan A; Albayrak N; Altaş AB
Mikrobiyol Bul; 2010 Jan; 44(1):57-64. PubMed ID: 20455399
[TBL] [Abstract][Full Text] [Related]
18. Nosocomial outbreak of Crimean-Congo haemorrhagic fever.
Naderi HR; Sarvghad MR; Bojdy A; Hadizadeh MR; Sadeghi R; Sheybani F
Epidemiol Infect; 2011 Jun; 139(6):862-6. PubMed ID: 20800007
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Crimean-Congo hemorrhagic fever.
Ergonul O
Antiviral Res; 2008 Apr; 78(1):125-31. PubMed ID: 18096251
[TBL] [Abstract][Full Text] [Related]
20. Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality.
Dokuzoguz B; Celikbas AK; Gök ŞE; Baykam N; Eroglu MN; Ergönül Ö
Clin Infect Dis; 2013 Nov; 57(9):1270-4. PubMed ID: 23946218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
